Client Groups

Faber has deep experience counseling a significant number of the most prominent U.S.-based life science venture capital and private equity firms. Our experience is broad, and we routinely guide investor clients on seed and later-stage financing transactions, new company incubation activities, and strategic transactions and exits impacting portfolio companies.

In each case, the Faber deal team brings to bear its deep experience serving as outside general or transactional counsel to its discovery and clinical stage therapeutic and other life science companies.

We know the pressure points because our team lives and breathes these deals and issues on a daily basis. The net result is sophisticated risk assessment and execution for our investor clients and, we think, portfolio companies left with a greater percentage of their financing proceeds to direct towards their important research and development objectives.